Page 98 - CIBERBBN-2015-eng

Research groups
Nanomedicine Group
Programme: Nanomedicine
Lead Researcher: Samitier Martí, Josep
Group members
STAFF MEMBERS: Lagunas Targarona, Anna | Mir Llorente, Mónica.
ASSOCIATED MEMBERS: Altay, Gizem | Alvira Torre, Margarita | Caballero Vila, David | Martínez Fraiz, Elena |
Montserrat Pulido, Nuria | Rigat Brugarolas, Luis.
CONTRIBUTORS: Funes Luque, Miriam | Hortigüela Lázaro, Verónica | Izquierdo García, David | Pardo, Wilmer Alfonso | Tahirbegi, Islam Bogachan | Zaffino, Rosa L.
Main lines of research
The scientific activity of NANOMED-IBEC group is focused in the application of nanotechnology and Bioengineering to the development of new diagnos- tic tools (point-of-care devices for diagnosis or for food safety applications) and to the development of organ-on-chip for in vitro studies.
To do that, the group is subdivided in three main re- search lines:
• Biosensors and Lab-on-a-chip for clinical diagno- sis and food safety applications: Development of DNA sensors for the detection of cancer bio- markers./ Development of antibody-based sen- sors for the detection of pathogen microorgan- isms./ Development of olfactory sensors based on G-protein coupled receptors for the detection of volatiles. / Development of ion-selective elec- trodes (ISE) for nutrient analysis. / Development
of sensors based on conducting polymers. / De- velopment of microfluidic platforms for simple handling and detection. / Development of micro- fluidic platforms for bacteria counting and sort- ing.
• Materials for the study of cellular response: De- sign, production and characterization of micro/ nanoenvironments made of different biocompat- ible materials for the study of cell proliferation, migration and differentiation. In particular, study of the effects of extracellular matrix. Which in- clude:
-Effects of nanoscale ligand distribution on cell adhesion and differentiation.
-Biophysics of migration and differentiation onto biological matrices.
-Study of interactions between magnetic nano- particles and cells.
98 I Annual report 2015 I CIBER-BBN